Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN) went up by 23.48% from its latest closing price compared to the recent 1-year high of $10.22. The company’s stock price has collected -48.71% of loss in the last five trading sessions.
Is It Worth Investing in Sonnet BioTherapeutics Holdings Inc. (NASDAQ :SONN) Right Now?
Plus, the 36-month beta value for SONN is at 0.59.
The average price from analysts is $22.00, which is $26.37 above the current price. SONN currently public float of 58.69M and currently shorts hold a 0.62% ratio of that float. Today, the average trading volume of SONN was 222.08K shares.
SONN’s Market Performance
SONN stocks went down by -48.71% for the week, with a monthly drop of -51.26% and a quarterly performance of -57.75%, while its annual performance rate touched -80.38%. The volatility ratio for the week stands at 38.72% while the volatility levels for the past 30 days are set at 17.70% for Sonnet BioTherapeutics Holdings Inc. The simple moving average for the period of the last 20 days is -41.48% for SONN stocks with a simple moving average of -62.89% for the last 200 days.
SONN Trading at -53.17% from the 50-Day Moving Average
After a stumble in the market that brought SONN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -84.05% of loss for the given period.
Volatility was left at 17.70%, however, over the last 30 days, the volatility rate increased by 38.72%, as shares sank -50.77% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -59.98% lower at present.
During the last 5 trading sessions, SONN fell by -48.71%, which changed the moving average for the period of 200-days by -76.72% in comparison to the 20-day moving average, which settled at $2.7014. In addition, Sonnet BioTherapeutics Holdings Inc. saw -71.82% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for SONN
Current profitability levels for the company are sitting at:
- -5187.36 for the present operating margin
The net margin for Sonnet BioTherapeutics Holdings Inc. stands at -5165.97. Equity return is now at value -243.90, with -161.80 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 4.30.